2020
DOI: 10.1186/s12904-020-00655-5
|View full text |Cite
|
Sign up to set email alerts
|

Views of advanced cancer patients, families, and oncologists on initiating and engaging in advance care planning: a qualitative study

Abstract: Background Advance care planning (ACP) is a process by which patients reflect upon their goals, values and beliefs to allow them to make decisions about their future medical treatment that align with their goals and values, improving patient-centered care. Despite this, ACP is underutilized and is reported as one of the most difficult processes of oncology. We sought to: 1) explore patients’ and families’ understanding, experience and reflections on ACP, as well as what they need from their phy… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
31
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(32 citation statements)
references
References 43 publications
0
31
0
1
Order By: Relevance
“…The advancing strength and clinical practice model were used to assess the methodological strength of the evidence (Melnyk & Fineout-Overholt, 2019). The strength of evidence among the studies varied and is consistent with level II (n = 4) randomized control trials (Bernacki et al, 2019;Epstein et al, 2018;Tang et al, 2019;Walczak et al, 2017), level III (n = 2) non-randomized control trial (Brohard, 2017;Rodenbach et al, 2017), level VI (n = 2) descriptive studies (Stegmann et al, 2020;Yoo et al, 2020), (n = 5) qualitative studies (Epstein et al, 2015;Geerse et al, 2019;Kumar et al, 2020;Paladino et al, 2020;Toguri et al, 2020), and (n = 2) mixed method studies (Agarwal et al, 2020;Michael et al, 2015).…”
Section: Data Appraisalmentioning
confidence: 52%
See 2 more Smart Citations
“…The advancing strength and clinical practice model were used to assess the methodological strength of the evidence (Melnyk & Fineout-Overholt, 2019). The strength of evidence among the studies varied and is consistent with level II (n = 4) randomized control trials (Bernacki et al, 2019;Epstein et al, 2018;Tang et al, 2019;Walczak et al, 2017), level III (n = 2) non-randomized control trial (Brohard, 2017;Rodenbach et al, 2017), level VI (n = 2) descriptive studies (Stegmann et al, 2020;Yoo et al, 2020), (n = 5) qualitative studies (Epstein et al, 2015;Geerse et al, 2019;Kumar et al, 2020;Paladino et al, 2020;Toguri et al, 2020), and (n = 2) mixed method studies (Agarwal et al, 2020;Michael et al, 2015).…”
Section: Data Appraisalmentioning
confidence: 52%
“…The literature supports the development of patient-provider relationship with trust development, and patients felt respected and empowered due to the ACP discussions (Agarwal et al, 2020;Kumar et al, 2020;Michael et al, 2015;Toguri et al, 2020). There was conflicting evidence related to the care which was based on goals and receipt of care at the end-of-life (Bernacki et al, 2019;Tang et al, 2019;Yoo et al, 2020).…”
Section: Con Clus Ionmentioning
confidence: 99%
See 1 more Smart Citation
“…Regarding the problem with ACP, Toguri et al evaluated the oncologist's views on ACP and reported that many oncologists found difficulty in determining an appropriate time of initiating ACP. [ 33 ] It has also been reported that if ACP was initiated too early, the decisions would be ambiguous, and if it were too late, it would be difficult to perform ACP itself. [ 34 ] Although the presence or absence of ACP could not be evaluated in this study, there was a 6-fold difference in post-cancer treatment prognosis between the self-decision group and the family's decision group.…”
Section: Discussionmentioning
confidence: 99%
“…While patients and families may recognise the importance of advance care planning, some may not feel comfortable initiating discussions about this with healthcare practitioners (Toguri et al 2020). The reasons for this discomfort may include the stigma around death and dying, religious beliefs, patient and family attitudes towards dying, different cultural beliefs among family members, family dynamics, and physical health issues such as confusion (Green et al 2015).…”
Section: Time Outmentioning
confidence: 99%